Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-21-000347
Filing Date
2021-01-12
Accepted
2021-01-12 17:02:59
Documents
1
Period of Report
2021-01-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 3529
  Complete submission text file 0001654954-21-000347.txt   5188
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 TOWNSEND DR. CLAYTON NC 27527
Business Address
Jebsen Michael B (Reporting) CIK: 0001481436 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34600 | Film No.: 21524128